This inventor holds 10 USPTO granted patents. Top assignees: Amgen Research (Munich) Gmbh, Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh, Bavarian Nordic A/s. Active years: 2002-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- München, DE (2002 - 2011)
- Munich, DE (2006 - 2014)
Company Filing History:
2 out of 77 
2 out of 9 
1 out of 135 
Years Active: 2002-2014
Title: The Innovative Contributions of Robert Saller
Introduction
Robert Saller is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of metastatic breast cancer. With a total of 10 patents to his name, Saller's work has the potential to impact many lives.
Latest Patents
Among his latest patents, Saller has developed a method involving the use of an anti-EpCAM antibody for the manufacture of a medicament aimed at treating metastatic breast cancer. This invention not only highlights his innovative approach but also emphasizes the importance of targeted therapies in modern medicine. The method of treating metastatic breast cancer involves administering the anti-EpCAM antibody, showcasing Saller's commitment to advancing cancer treatment.
Career Highlights
Throughout his career, Robert Saller has worked with prominent organizations, including Amgen Research GmbH in Munich. His experience in such a reputable company has allowed him to refine his skills and contribute to groundbreaking research in the medical field.
Collaborations
Saller has collaborated with several professionals in his field, including Brian Salmons and Carsten Reinhardt. These collaborations have likely enriched his research and led to innovative solutions in cancer treatment.
Conclusion
Robert Saller's contributions to the field of medical research, particularly in the treatment of metastatic breast cancer, demonstrate his dedication to innovation. His patents and collaborations reflect a commitment to improving patient outcomes through advanced therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile